Literature DB >> 22226664

Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells.

Mutsushi Yamasaki1, Takeo Nomura, Fuminori Sato, Hiromitsu Mimata.   

Abstract

PURPOSE: Tumor hypoxia is a common feature of any cancer, including prostate cancer (CaP), and associated with tumor cell aggressiveness. Although some reports are available on acute hypoxia-response in CaP cells aggressiveness, little is known about chronic hypoxia-response. We investigated the effects of chronic hypoxia on human CaP cells.
MATERIALS AND METHODS: The human androgen-dependent CaP cell line LNCaP was cultured under normoxia (21% O2), acute hypoxia (1% O2), or chronic hypoxia (1% O2 for over 6 months). The cell growth, cell cycle and cell behavior of these cells were analyzed by cell count, flow cytometric analysis and in vitro cell migration and invasion assay, respectively. The expression of matrix metalloproteinases and intracellular signaling pathways were tested by real time reverse transcriptase-polymerase chain reaction and Western blotting.
RESULTS: Chronic hypoxia-conditioned LNCaP cells grew in an androgen-independent manner with acceleration of G1 to S phase cell cycle progression. Chronic hypoxia, but not acute hypoxia, accelerated cell migration and invasion. The expressions of matrix metalloproteinase-7, -9, -14, and -15 were significantly up-regulated in LNCaP cells under chronic hypoxia, but not under acute hypoxia. In addition, PI3K/Akt, JAK/STAT, and HIF-1 pathways were activated in chronic hypoxia-conditioned LNCaP cells.
CONCLUSIONS: These results suggested that chronic hypoxia plays an important role in enhancement of malignant potential during androgen-independent CaP progression.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell growth; Cell invasion; Chronic hypoxia; Prostate cancer

Mesh:

Substances:

Year:  2012        PMID: 22226664     DOI: 10.1016/j.urolonc.2011.12.007

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  15 in total

Review 1.  Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.

Authors:  Gagan Deep; Gati K Panigrahi
Journal:  Crit Rev Oncog       Date:  2015

2.  Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.

Authors:  Kumar Nikhil; Lei Chang; Keith Viccaro; Max Jacobsen; Callista McGuire; Shakti R Satapathy; Michael Tandiary; Meaghan M Broman; Gregory Cresswell; Yizhou J He; George E Sandusky; Timothy L Ratliff; Dipanjan Chowdhury; Kavita Shah
Journal:  Cancer Lett       Date:  2019-02-01       Impact factor: 8.679

Review 3.  Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.

Authors:  Loredana Puca; Panagiotis J Vlachostergios; Himisha Beltran
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

Review 4.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

5.  SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3.

Authors:  Jun Wan; Yun Che; Ningning Kang; Wei Wu
Journal:  Mol Med Rep       Date:  2015-02-17       Impact factor: 2.952

6.  The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.

Authors:  Mark P Labrecque; Mandeep K Takhar; Rebecca Nason; Stephanie Santacruz; Kevin J Tam; Shabnam Massah; Anne Haegert; Robert H Bell; Manuel Altamirano-Dimas; Colin C Collins; Frank J S Lee; Gratien G Prefontaine; Michael E Cox; Timothy V Beischlag
Journal:  Oncotarget       Date:  2016-04-26

7.  Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression.

Authors:  Claire Tonry; John Armstrong; Stephen Pennington
Journal:  Oncotarget       Date:  2017-02-28

8.  Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.

Authors:  Takeo Nomura; Mutsushi Yamasaki; Kenichi Hirai; Toru Inoue; Ryuta Sato; Keiko Matsuura; Masatsugu Moriyama; Fuminori Sato; Hiromitsu Mimata
Journal:  Mol Cancer       Date:  2013-04-08       Impact factor: 27.401

9.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2013-01-10       Impact factor: 5.310

10.  REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.

Authors:  Tzu-Ping Lin; Yi-Ting Chang; Sung-Yuan Lee; Mel Campbell; Tien-Chiao Wang; Shu-Huei Shen; Hsiao-Jen Chung; Yen-Hwa Chang; Allen W Chiu; Chin-Chen Pan; Chi-Hung Lin; Cheng-Ying Chu; Hsing-Jien Kung; Chia-Yang Cheng; Pei-Ching Chang
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.